{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:14:33Z","timestamp":1760908473322},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.ejim.2008.04.015","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T05:05:53Z","timestamp":1214456753000},"page":"96-99","source":"Crossref","is-referenced-by-count":16,"title":["Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Semra","family":"Paydas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan","family":"Bicakci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2008.04.015_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.breast.2005.03.006","article-title":"Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse","volume":"15","author":"Hikino","year":"2006","journal-title":"The Breast"},{"key":"10.1016\/j.ejim.2008.04.015_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000421-200108000-00026","article-title":"Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer","volume":"24","author":"Wang","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejim.2008.04.015_bib3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:NEON.0000003752.89814.ca","article-title":"Response of neoplastic meningitis from solid tumors to oral capecitabine","volume":"65","author":"Giglio","year":"2003","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejim.2008.04.015_bib4","first-page":"63","article-title":"Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy","volume":"6","author":"Rogers","year":"2004","journal-title":"Neurooncology"},{"key":"10.1016\/j.ejim.2008.04.015_bib5","first-page":"1139","article-title":"Induction of thymidine phosphorylase in both irradiated and shielded, contralateral human U87MG glioma xenografts: implications for a dual modality treatment using capecitabine and irradiation","volume":"1","author":"Blanquicett","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejim.2008.04.015_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/07357900600705805","article-title":"Dramatic regression of multiple brain metastases from breast cancer with capectabine: another arrow at the bow?","volume":"24","author":"Fabi","year":"2006","journal-title":"Cancer Investigation"},{"key":"10.1016\/j.ejim.2008.04.015_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00280-005-0159-4","article-title":"5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma","volume":"58","author":"Formica","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejim.2008.04.015_bib8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/A:1010939329562","article-title":"A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU","volume":"18","author":"Tsukamot","year":"2001","journal-title":"Pharm Res"},{"key":"10.1016\/j.ejim.2008.04.015_bib9","first-page":"2948","article-title":"X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine in human xenografts","volume":"5","author":"Sawada","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejim.2008.04.015_bib10","first-page":"2006","article-title":"Life threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil","volume":"5","author":"Johnson","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejim.2008.04.015_bib11","first-page":"2203","article-title":"Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile","volume":"47","author":"Heggie","year":"1987","journal-title":"Cancer Res"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620508001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T10:58:10Z","timestamp":1545908290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620508001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0953620508001507"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2008.04.015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}